Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAAS
5926
DELISTED
inContact, Inc.
SAAS
| $11K | ﹤0.01% |
1,177
-8,246
| -88% | -$84.4K |
|
|
SGNT
5927
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $11K | ﹤0.01% |
454
-626
| -58% | -$15K |
|
|
CKP
5928
DELISTED
CHECKPOINT SYSTEMS INC
CKP
| $11K | ﹤0.01% |
1,098
-2,329
| -68% | -$24.5K |
|
|
CHU
5929
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $11K | ﹤0.01% |
705
-2,654
| -79% | -$46.5K |
|
|
OSIR
5930
CALL
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $11K | ﹤0.01% |
600
-16,600
| -97% | -$294K |
|
|
PLCM
5931
CALL
DELISTED
POLYCOM INC
PLCM
| $11K | ﹤0.01% |
1,000
+300
| +43% | +$3.92K |
|
|
AMCC
5932
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $11K | ﹤0.01% |
1,799
-39,119
| -96% | -$239K |
|
|
ACRE
5933
Ares Commercial Real Estate
ACRE
$236M
| $10K | ﹤0.01% |
862
-346
| -29% | -$3.98K |
|
5934
Argan
AGX
$8B
| $10K | ﹤0.01% |
247
-128
| -34% | -$4.58K |
|
5935
Anterix
ATEX
$1.81B
| $10K | ﹤0.01% |
+248
| New | +$11.7K |
|
5936
AeroVironment
AVAV
$7.56B
| $10K | ﹤0.01% |
378
-2,828
| -88% | -$74.6K |
|
5937
Bank of America Series L
BAC.PRL
$3.97B
| $10K | ﹤0.01% |
9
-148
| -94% | -$170K |
|
5938
CALL
Bruker
BRKR
$9.57B
| $10K | ﹤0.01% |
500
+200
| +67% | +$4.04K |
|
5939
CALL
BWX Technologies
BWXT
$15.5B
| $10K | ﹤0.01% |
419
-140
| -25% | -$3.29K |
|
5940
Chegg
CHGG
$110M
| $10K | ﹤0.01% |
1,460
-25,073
| -94% | -$198K |
|
5941
Celestica
CLS
$38.1B
| $10K | ﹤0.01% |
940
+838
| +822% | +$10.2K |
|
5942
Community Trust Bancorp
CTBI
$1.42B
| $10K | ﹤0.01% |
300
-169
| -36% | -$5.62K |
|
5943
Entravision Communication
EVC
$1.03B
| $10K | ﹤0.01% |
1,218
-517
| -30% | -$3.59K |
|
5944
First Interstate BancSystem
FIBK
$3.69B
| $10K | ﹤0.01% |
377
-170
| -31% | -$4.71K |
|
5945
Griffon
GFF
$3.95B
| $10K | ﹤0.01% |
679
-3,643
| -84% | -$60.3K |
|
5946
Gorman-Rupp
GRC
$2.14B
| $10K | ﹤0.01% |
364
-197
| -35% | -$5.57K |
|
5947
Installed Building Products
IBP
$6.01B
| $10K | ﹤0.01% |
424
+169
| +66% | +$3.81K |
|
5948
Interparfums
IPAR
$3.99B
| $10K | ﹤0.01% |
325
-177
| -35% | -$5.86K |
|
5949
Kadant
KAI
$3.63B
| $10K | ﹤0.01% |
210
-122
| -37% | -$6.08K |
|
5950
Kforce
KFRC
$1.02B
| $10K | ﹤0.01% |
473
-275
| -37% | -$6.11K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.